Scott Juda serves as Executive at Inmune Bio, Inc., where they oversee executive responsibilities. Since joining the company, Scott Juda has executed 8 insider transactions totaling $455.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 25, 2024 involved purchasing 5,000 shares valued at $36.4K.
Scott Juda currently holds 71,603 shares of Inmune Bio, Inc. (INMB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Juda has been a net buyer of INMB stock. They have purchased $455.2K and sold $0 worth of shares.
Scott Juda's most recent insider trade was on Jun 25, 2024, when they purchased 5,000 shares at $7.27 per share.
Get notified when new Form 4 filings are submitted
| $8.32 |
| Discretionary |
| Apr 19, 2024 | INMB | $246.3K | Purchase | 29,603 | $8.32 | Discretionary |
| Nov 10, 2023 | INMB | $48.6K | Purchase | 7,000 | $6.95 | Discretionary |
| Nov 17, 2021 | INMB | $33.9K | Purchase | 2,500 | $13.55 | Discretionary |
| Aug 21, 2019 | INMB | $15.0K | Purchase | 2,500 | $6.00 | Discretionary |
| Aug 20, 2019 | INMB | $15.0K | Purchase | 2,500 | $6.00 | Discretionary |
| Jun 3, 2019 | INMB | $60.0K | Purchase | 10,000 | $6.00 | Discretionary |